Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Journal of Inherited Metabolic Disease
|
October 6, 2017
Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)
Gerald Salen, Robert D Steiner
Cardiovascular Drug Reviews
|
December 14, 2002
Sitosterolemia
Gerald Salen, Shailesh Patel, A K Batta
Metabolism: Clinical and Experimental
|
May 8, 2004
Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis
Ashok K Batta, Gerald Salen, G Stephen Tint
Gastroenterology
|
May 16, 2006
Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis
Gerald Salen, Thomas Starc, Christine McCrary Sisk, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 2, 2010
Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1
Quan Shang, Monica Saumoy, Jens Juul Holst, et al.
Archives of Neurology
|
April 10, 2002
Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations
Mohammed H Moghadasian, Gerald Salen, Jiri J Frohlich, et al.
The American Journal of Gastroenterology
|
June 4, 2009
Splenic injury as a complication of colonoscopy: a case series
Kiran V Rao, Gagan D Beri, Mark J Sterling, et al.
Metabolism: Clinical and Experimental
|
February 18, 2006
Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat
Ashok K Batta, Guorong Xu, Akira Honda, et al.
Metabolism: Clinical and Experimental
|
November 25, 2004
Effect of high plant sterol-enriched diet and cholesterol absorption inhibitor, SCH 58235, on plant sterol absorption and plasma concentrations in hypercholesterolemic wild-type Kyoto rats
Ashok K Batta, Guorong Xu, Jaya S Bollineni, et al.
Journal of Lipid Research
|
July 16, 2013
FGF15/19 protein levels in the portal blood do not reflect changes in the ileal FGF15/19 or hepatic CYP7A1 mRNA levels
Quan Shang, Grace L Guo, Akira Honda, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Journal of Inherited Metabolic Disease
|
October 6, 2017
Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX)
Gerald Salen, Robert D Steiner
Cardiovascular Drug Reviews
|
December 14, 2002
Sitosterolemia
Gerald Salen, Shailesh Patel, A K Batta
Metabolism: Clinical and Experimental
|
May 8, 2004
Hydrophilic 7 beta-hydroxy bile acids, lovastatin, and cholestyramine are ineffective in the treatment of cerebrotendinous xanthomatosis
Ashok K Batta, Gerald Salen, G Stephen Tint
Gastroenterology
|
May 16, 2006
Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis
Gerald Salen, Thomas Starc, Christine McCrary Sisk, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
January 2, 2010
Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1
Quan Shang, Monica Saumoy, Jens Juul Holst, et al.
Archives of Neurology
|
April 10, 2002
Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations
Mohammed H Moghadasian, Gerald Salen, Jiri J Frohlich, et al.
The American Journal of Gastroenterology
|
June 4, 2009
Splenic injury as a complication of colonoscopy: a case series
Kiran V Rao, Gagan D Beri, Mark J Sterling, et al.
Metabolism: Clinical and Experimental
|
February 18, 2006
Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat
Ashok K Batta, Guorong Xu, Akira Honda, et al.
Metabolism: Clinical and Experimental
|
November 25, 2004
Effect of high plant sterol-enriched diet and cholesterol absorption inhibitor, SCH 58235, on plant sterol absorption and plasma concentrations in hypercholesterolemic wild-type Kyoto rats
Ashok K Batta, Guorong Xu, Jaya S Bollineni, et al.
Journal of Lipid Research
|
July 16, 2013
FGF15/19 protein levels in the portal blood do not reflect changes in the ileal FGF15/19 or hepatic CYP7A1 mRNA levels
Quan Shang, Grace L Guo, Akira Honda, et al.
Page
of 5